
    
      Patients allergic to the specific pollen are divided into two groups randomly. One group is
      being administered Lectranal and the other group is being administered placebo during the
      period of 6 weeks in season of the pollen. Methods used for evaluation are: SARS
      questionnaire(seasonal allergic rhinitis symptoms), Mini RQLQ (mini rhinoconjunctivitis
      quality of life questionnaire) skin Prick test, specific IgE and IgG, eosinophilia in nasal
      secretion. Methods used for follow up safety include side effects report, physical
      examination and vital signs.
    
  